دورية أكاديمية
أعرض في EDS

Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus.

التفاصيل البيبلوغرافية
العنوان: Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus.
المؤلفون: Pinto-Peñaranda LF; Rheumatology Department, Hospital Pablo Tobón Uribe, Calle 78B 69 - 240, Medellin, Colombia. lfpreumatologo@hotmail.com., Muñoz-Grajales C; Rheumatology Department, Hospital Pablo Tobón Uribe, Calle 78B 69 - 240, Medellin, Colombia., Echeverri Garcia AF; Rheumatology Department, Hospital Pablo Tobón Uribe, Calle 78B 69 - 240, Medellin, Colombia., Velásquez-Franco CJ; Rheumatology Section, Clinica Universitaria Universidad Pontificia Bolivariana, Medellin, Colombia., Mesa-Navas MA; Rheumatology Section, Clinica Universitaria Universidad Pontificia Bolivariana, Medellin, Colombia., Zuluaga Quintero M; Internal Medicine Department, Hospital Pablo Tobon Uribe, Medellin, Colombia., Herrera-Uribe S; Hospital General de Medellin, Art Medica, Medellin, Colombia., Márquez-Hernández JD; Rheumatology Department, Hospital Pablo Tobón Uribe, Calle 78B 69 - 240, Medellin, Colombia.
المصدر: Clinical rheumatology [Clin Rheumatol] 2018 Apr; Vol. 37 (4), pp. 949-954. Date of Electronic Publication: 2017 Dec 04.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE
أسماء مطبوعة: Publication: <2008->: Heidelberg : Springer
Original Publication: Brussels : Acta Medica Belgica, [1982-
مواضيع طبية MeSH: Antibodies, Antiphospholipid/*blood , Hypertension/*physiopathology , Kidney/*physiopathology , Lupus Erythematosus, Systemic/*immunology, Adolescent ; Adult ; Colombia ; Disease Progression ; Female ; Humans ; Lupus Erythematosus, Systemic/drug therapy ; Lupus Erythematosus, Systemic/physiopathology ; Male ; Middle Aged ; Recurrence ; Retrospective Studies ; Severity of Illness Index ; Young Adult
مستخلص: Organ damage predicts mortality, increased accrual of detriment, and poor quality of life in systemic lupus erythematosus patients. The objective of this study is to determine the damage-free survival and its predictive factors in a population of Colombian subjects. The method used in this study is the retrospective follow-up of a cohort; damage was measured with SLICC/ACR index. Predictors of impairment were assessed by logistic regression and survival analysis. One hundred sixty-one individuals were included; 28.9% suffered damage, primarily neuropsychiatric, renal, and vascular. Arterial hypertension, antiphospholipid antibodies, prednisone dose, and number of relapses were all predictors of detriment. Onset after age 50 and daily prednisone dose higher than 7.5 mg determined earlier occurrence of damage.
References: Arthritis Rheum. 2006 May;54(5):1580-7. (PMID: 16645994)
Lupus. 2016 Jun;25(7):719-26. (PMID: 26821965)
J Rheumatol. 1992 Nov;19(11):1820-1. (PMID: 1362779)
Ann Rheum Dis. 2015 Jun;74(6):1019-23. (PMID: 24525909)
Lupus. 2007;16(5):309-17. (PMID: 17576731)
J Rheumatol. 2003 Sep;30(9):1955-9. (PMID: 12966597)
Am J Med. 2006 Aug;119(8):700-6. (PMID: 16887417)
J Rheumatol. 2002 May;29(5):913-7. (PMID: 12022349)
Lupus. 2008 Nov;17(11):1023-8. (PMID: 18852227)
Arthritis Care Res. 1995 Sep;8(3):137-45. (PMID: 7654797)
Arthritis Care Res (Hoboken). 2012 Jan;64(1):132-7. (PMID: 21954226)
Lupus. 2006;15(8):515-20. (PMID: 16942004)
Arch Intern Med. 2004 Jan 12;164(1):77-82. (PMID: 14718326)
J Rheumatol. 1998 Apr;25(4):654-9. (PMID: 9558165)
Rheumatology (Oxford). 2003 Feb;42(2):276-9. (PMID: 12595622)
J Rheumatol. 2009 Mar;36(3):560-4. (PMID: 19208608)
Arthritis Rheum. 1992 Jun;35(6):630-40. (PMID: 1599520)
Arthritis Rheum. 2002 Feb;46(2):436-44. (PMID: 11840446)
Ann Rheum Dis. 2002 May;61(5):409-13. (PMID: 11959764)
Rheumatology (Oxford). 2014 Aug;53(8):1470-6. (PMID: 24681836)
Rheumatology (Oxford). 2004 Aug;43(8):1039-44. (PMID: 15161983)
Lupus. 1997;6(3):243-7. (PMID: 9104730)
Rheumatology (Oxford). 2009 Jun;48(6):673-5. (PMID: 19359343)
Lupus. 2010 Jul;19(8):949-56. (PMID: 20375124)
Arthritis Rheum. 1990 Jan;33(1):37-48. (PMID: 2302266)
Lupus. 2004;13(12):900-5. (PMID: 15645743)
Rheumatology (Oxford). 2004 Dec;43(12):1555-60. (PMID: 15342927)
J Rheumatol. 2001 Mar;28(3):525-32. (PMID: 11296953)
Arthritis Rheum. 2010 Mar;62(3):855-62. (PMID: 20131238)
Autoimmun Rev. 2004 Jun;3(4):321-9. (PMID: 15246029)
Semin Arthritis Rheum. 2012 Jun;41(6):830-9. (PMID: 22257558)
Lupus. 2001;10(2):93-6. (PMID: 11237132)
Arthritis Rheum. 2000 Aug;43(8):1801-8. (PMID: 10943870)
Br J Rheumatol. 1996 Mar;35(3):248-54. (PMID: 8620300)
Reumatol Clin. 2010 Jan-Feb;6(1):11-5. (PMID: 21794672)
Arthritis Rheum. 2004 Oct;50(10):3177-86. (PMID: 15476246)
J Rheumatol. 2008 Nov;35(11):2152-8. (PMID: 18793004)
Lupus. 2015 Jul;24(8):788-95. (PMID: 25504653)
Clin Rheumatol. 2007 Dec;26(12):2017-2022. (PMID: 17415506)
Ann N Y Acad Sci. 2009 Sep;1173:822-8. (PMID: 19758234)
Lupus. 2006;15(12):892-8. (PMID: 17211998)
فهرسة مساهمة: Keywords: Organ damage; SLICC/ACR SDI; Systemic lupus erythematosus
المشرفين على المادة: 0 (Antibodies, Antiphospholipid)
تواريخ الأحداث: Date Created: 20171206 Date Completed: 20180907 Latest Revision: 20210109
رمز التحديث: 20221213
DOI: 10.1007/s10067-017-3927-8
PMID: 29204758
قاعدة البيانات: MEDLINE
الوصف
تدمد:1434-9949
DOI:10.1007/s10067-017-3927-8